Diabetes, metabolic syndrome and dyslipidemia in people living with HIV in Africa: re-emerging challenges not to be forgotten

References

• HusainNEAhmedMHManaging dyslipidemia in HIV/AIDS patients: challenges and solutionsHiv/Aids2015711025565897
   PubMedGoogle Scholar
• MenezesCNCrowtherNJDuarteRA randomized clinical trial comparing metabolic parameters after 48 weeks of standard- and low-dose stavudine therapy and tenofovir disoproxil fumarate therapy in HIV-infected South African patientsHIV Med201415131223980620
   PubMed Web of Science ®Google Scholar
• LedergerberBFurrerHRickenbachMSwiss HIV Cohort StudyFactors associated with the incidence of type 2 diabetes mellitus in HIV-infected participants in the Swiss HIV Cohort StudyClin Infect Dis200745111111917554711
   PubMed Web of Science ®Google Scholar
• TripathiAJerrellJMLieseADAssociation of clinical and therapeutic factors with incident dyslipidemia in a cohort of human immunodeficiency virus-infected and non-infected adults: 1994–2011Metab Syndr Relat Disord201311641742623909647
   PubMed Web of Science ®Google Scholar
• WangKLLiuCJChaoTFStatins, risk of diabetes, and implications on outcomes in the general populationJ Am Coll Cardiol201260141231123822884288
   PubMed Web of Science ®Google Scholar
• RidkerPMPradhanAMacFadyenJGLibbyPGlynnRJCardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trialLancet2012380984156557122883507
   PubMed Web of Science ®Google Scholar
• SmithCSabinCALundgrenJDData Collection on Adverse Events of Anti-HIV drugs (D:A:D) Study GroupFactors associated with specific causes of death amongst HIV-positive individuals in the D:A:D StudyAIDS201024101537154820453631
   PubMed Web of Science ®Google Scholar
• NguyenKAPeerNMillsEJKengneAPA meta-analysis of the metabolic syndrome prevalence in the global HIV-infected populationPLoS One2016113e015097027008536
   PubMed Web of Science ®Google Scholar
• GrundySMMetabolic syndrome pandemicArterioscler Thromb Vasc Biol200828462963618174459
   PubMed Web of Science ®Google Scholar
• Márquez-SandovalFMacedo-OjedaGViramontes-HörnerDFernández BallartJDSalas SalvadóJVizmanosBThe prevalence of metabolic syndrome in Latin America: a systematic reviewPublic Health Nutr201114101702171321486521
   PubMed Web of Science ®Google Scholar
• GamiASWittBJHowardDEMetabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studiesJ Am Coll Cardiol200749440341417258085
   PubMed Web of Science ®Google Scholar
• EdwardsJKBygraveHVan den BerghRHIV with non-communicable diseases in primary care in Kibera, Nairobi, Kenya: characteristics and outcomes 2010–2013Trans R Soc Trop Med Hyg201510944044625997923
   PubMed Web of Science ®Google Scholar
• HadiganCKattakuzhySDiabetes mellitus type 2 and abnormal glucose metabolism in the setting of human immunodeficiency virusEndocrinol Metab Clin North Am201443368569625169561
   PubMed Web of Science ®Google Scholar
• WatkinsDATullochNLAndersonMEBarnhartSSteynKLevittNSDelivery of health care for cardiovascular and metabolic diseases among people living with HIV/AIDS in African countries: a systematic review protocolSyst Rev201656327084509
   PubMedGoogle Scholar
• MugishaJOSchatzEJRandellMChronic disease, risk factors and disability in adults aged 50 and above living with and without HIV: findings from the Well-being of Older People Study in UgandaGlob Health Action2016931098
   PubMed Web of Science ®Google Scholar
• PillaySAldousCMahomedFA deadly combination – HIV and diabetes mellitus: Where are we now?S Afr Med J201610645427032854
   PubMedGoogle Scholar
• LevittNSPeerNSteynKIncreased risk of dysglycaemia in South Africans with HIV; especially those on protease inhibitorsDiabetes Res Clin Pract2016119414727423428
   PubMed Web of Science ®Google Scholar
• SteinicheDJespersenSErikstrupCBissau HIV Cohort Study GroupDiabetes mellitus and impaired fasting glucose in ART-naive patients with HIV-1, HIV-2 and HIV-1/2 dual infection in Guinea-Bissau: a cross-sectional studyTrans R Soc Trop Med Hyg2016110421922727076509
   PubMed Web of Science ®Google Scholar
• RheeJYBahtilaTDPalmerDPrevalence of and factors associated with prediabetes and diabetes among HIV-infected adults in CameroonDiabetes Metab Res Rev201632654454926891253
   PubMed Web of Science ®Google Scholar
• AbrahamsZDaveJAMaartensGLevittNSChanges in blood pressure, glucose levels, insulin secretion and anthropometry after long term exposure to antiretroviral therapy in South African womenAIDS Res Ther2015122426251665
   PubMed Web of Science ®Google Scholar
• KhabalaKBEdwardsJKBaruaniBMedication adherence clubs: a potential solution to managing large numbers of stable patients with multiple chronic diseases in informal settlementsTrop Med Int Health201520101265127025962952
   PubMed Web of Science ®Google Scholar
• MagodoroIMEsterhuizenTMChiveseTA cross-sectional, facility based study of comorbid non-communicable diseases among adults living with HIV infection in ZimbabweBMC Res Notes2016937927484005
   PubMedGoogle Scholar
• AdeniyiOVYogeswaranPLongo-MbenzaBTer GoonDAjayiAICross-sectional study of patients with type 2 diabetes in OR Tambo district, South AfricaBMJ Open20166e010875
   PubMed Web of Science ®Google Scholar
• ErlandsonKMKitchDTierneyCImpact of randomized anti-retroviral therapy initiation on glucose metabolismAIDS201428101451146124637543
   PubMed Web of Science ®Google Scholar
• TzurFChowersMAgmon-LevinNMekoriYAHershkoAYIncreased prevalence of diabetes mellitus in a non-obese adult population: HIV-infected EthiopiansIsr Med Assoc J2015171062062326665316
   PubMed Web of Science ®Google Scholar
• KoetheJRJenkinsCAPetucciCCulverJShepherdBESterlingTRSuperior glucose tolerance and metabolomic profiles, independent of adiposity, in HIV-infected women compared with men on antiretroviral therapyMedicine (Baltimore)20169519e363427175676
   PubMed Web of Science ®Google Scholar
• SamarasKPrevalence and pathogenesis of diabetes mellitus in HIV-1 infection treated with combined antiretroviral therapyJ Acquir Immune Defic Syndr200950549950519223782
   PubMed Web of Science ®Google Scholar
• DimalaCAAtashiliJMbuagbawJCWilfredAMonekossoGLA comparison of the diabetes risk score in HIV/AIDS patients on highly active antiretroviral therapy (HAART) and HAART-naive patients at the Limbe Regional Hospital, CameroonPLoS One2016115e015556027195956
   PubMed Web of Science ®Google Scholar
• CarrASamarasKThorisdottirAKaufmannGRChisholmDJCooperDADiagnosis, prediction, and natural course of HIV-1 protease- inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort studyLancet199935391702093209910382692
   PubMed Web of Science ®Google Scholar
• MurataHHruzPWMuecklerMThe mechanism of insulin resistance caused by HIV protease inhibitor therapyJ Biol Chem200027527202512025410806189
   PubMed Web of Science ®Google Scholar
• DaveJALambertEVBadriMWestSMaartensGLevittNSEffect of nonnucleoside reverse transcriptase inhibitor-based antiretroviral therapy on dysglycemia and insulin sensitivity in South African HIV-infected patientsJ Acquir Immune Defic Syndr201157428428921602696
   PubMed Web of Science ®Google Scholar
• De WitSSabinCAWeberRData Collection on Adverse Events of Anti-HIV Drugs (D:A:D) studyIncidence and risk factors for new-onset diabetes in HIV-infected patients: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) studyDiabetes Care20083161224122918268071
   PubMed Web of Science ®Google Scholar
• RasmussenLDMathiesenERKronborgGPedersenCGerstoftJObelNRisk of diabetes mellitus in persons with and without HIV: a Danish nationwide population-based cohort studyPLoS One201279e4457522984529
   PubMed Web of Science ®Google Scholar
• MagangaESmartLRKalluvyaSGlucose metabolism disorders, HIV and antiretroviral therapy among Tanzanian adultsPLoS One2015108e013441026287742
   PubMed Web of Science ®Google Scholar
• MartinezEArnaizJAPodzamczerDNevirapine, Efavirenz, and Abacavir (NEFA) Study TeamSubstitution of nevirapine, efavirenz, or abacavir for protease inhibitors in patients with human immunodeficiency virus infectionN Engl J Med2003349111036104612968087
   PubMed Web of Science ®Google Scholar
• JemsekJGArathoonEArlottiMBody fat and other metabolic effects of atazanavir and efavirenz, each administered in combination with zidovudine plus lamivudine, in antiretroviral-naive HIV-infected patientsClin Infect Dis200642227328016355341
   PubMed Web of Science ®Google Scholar
• LennoxJLDejesusEBergerDSSTARTMRK InvestigatorsRaltegravir versus Efavirenz regimens in treatment-naive HIV-1-infected patients: 96-week efficacy, durability, subgroup, safety, and metabolic analysesJ Acquir Immune Defic Syndr2010551394820404738
   PubMed Web of Science ®Google Scholar
• FisacCFumeroECrespoMMetabolic benefits 24 months after replacing a protease inhibitor with abacavir, efavirenz or nevirapineAIDS200519991792515905672
   PubMed Web of Science ®Google Scholar
• KaramchandSLeisegangRSchomakerMRisk factors for incident diabetes in a cohort taking first-line nonnucleoside reverse transcriptase inhibitor-based antiretroviral therapyMedicine (Baltimore)2016959e284426945366
   PubMed Web of Science ®Google Scholar
• ManuthuEMJoshiMDLuleGNKarariEPrevalence of dyslipidemia and dysglycaemia in HIV infected patientsEast Afr Med J2008851101718543521
   PubMedGoogle Scholar
• EkaliLGJohnstoneLKEchouffo-TcheuguiJBFasting blood glucose and insulin sensitivity are unaffected by HAART duration in Cameroonians receiving first-line antiretroviral treatmentDiabetes Metab2013391717723153435
   PubMed Web of Science ®Google Scholar
• CarrASamarasKBurtonSA syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitorsAIDS1998127F51F589619798
   PubMed Web of Science ®Google Scholar
• CarrASamarasKChisholmDJCooperDAPathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistanceLancet19983519119188118839652687
   PubMed Web of Science ®Google Scholar
• GanSKSamarasKCarrAChisholmDAnti-retroviral therapy, insulin resistance and lipodystrophyDiabetes Obes Metab200132677111298728
   PubMed Web of Science ®Google Scholar
• NoorMASeneviratneTAweekaFTIndinavir acutely inhibits insulin-stimulated glucose disposal in humans: a randomized, placebo-controlled studyAIDS2002165F1F811964551
   PubMed Web of Science ®Google Scholar
• HommesMJRomijnJAEndertEEeftinck SchattenkerkJKSauerweinHPInsulin sensitivity and insulin clearance in human immunodeficiency virus-infected menMetabolism19914066516561865829
   PubMed Web of Science ®Google Scholar
• CaronMAuclairMVigourouxCGlorianMForestCCapeauJThe HIV protease inhibitor indinavir impairs sterol regulatory element-binding protein-1 intranuclear localization, inhibits preadipocyte differentiation, and induces insulin resistanceDiabetes20015061378138811375339
   PubMed Web of Science ®Google Scholar
• AyinaCNNoubiapJJEtoundi NgoaLSAssociation of serum leptin and adiponectin with anthropomorphic indices of obesity, blood lipids and insulin resistance in a Sub-Saharan African populationLipids Health Dis2016159627189377
   PubMed Web of Science ®Google Scholar
• GanSKSamarasKThompsonCHAltered myocellular and abdominal fat partitioning predict disturbance in insulin action in HIV protease inhibitor-related lipodystrophyDiabetes200251113163316912401706
   PubMed Web of Science ®Google Scholar
• BlumerRMvan VonderenMGSutinenJZidovudine/lamivudine contributes to insulin resistance within 3 months of starting combination antiretroviral therapyAIDS200822222723618097225
   PubMed Web of Science ®Google Scholar
• FleischmanAJohnsenSSystromDMEffects of a nucleoside reverse transcriptase inhibitor, stavudine, on glucose disposal and mitochondrial function in muscle of healthy adultsAm J Physiol Endocrinol Metab20072926E1666E167317284576
   PubMed Web of Science ®Google Scholar
• MallonPWUnemoriPSedwellRSAMA InvestigatorsIn vivo, nucleoside reverse-transcriptase inhibitors alter expression of both mitochondrial and lipid metabolism genes in the absence of depletion of mitochondrial DNAJ Infect Dis2005191101686169615838796
   PubMed Web of Science ®Google Scholar
• WoerleHJMariuzPRMeyerCMechanisms for the deterioration in glucose tolerance associated with HIV protease inhibitor regimensDiabetes200352491892512663461
   PubMed Web of Science ®Google Scholar
• BehrensGDejamASchmidtHImpaired glucose tolerance, beta cell function and lipid metabolism in HIV patients under treatment with protease inhibitorsAIDS19991310F63F7010416516
   PubMed Web of Science ®Google Scholar
• KosterJCRemediMSQiuHNicholsCGHruzPWHIV protease inhibitors acutely impair glucose-stimulated insulin releaseDiabetes20035271695170012829635
   PubMed Web of Science ®Google Scholar
• WinchesterMSBeLueROniTThe Pan-University Network for Global Health: framework for collaboration and review of global health needsGlobal Health2016121327097634
   PubMed Web of Science ®Google Scholar
• MendenhallENorrisSAWhen HIV is ordinary and diabetes new: remaking suffering in a South African townshipGlob Public Health201510444946225643001
   PubMed Web of Science ®Google Scholar
• KagarukiGBMayigeMTNgadayaESMagnitude and risk factors of non-communicable diseases among people living with HIV in Tanzania: a cross sectional study from Mbeya and Dar es Salaam regionsBMC Public Health20141490425183300
   PubMed Web of Science ®Google Scholar
• MendenhallEOmondiGBBosireEStress, diabetes, and infection: syndemic suffering at an urban Kenyan hospitalSoc Sci Med2015146112026476849
   PubMed Web of Science ®Google Scholar
• DagaduHEPattersonEJPlacing a health equity lens on non-communicable diseases in sub-Saharan AfricaJ Health Care Poor Underserved201526396798926320927
   PubMed Web of Science ®Google Scholar
• GradidgePJCrowtherNJReview: metabolic syndrome in Black South African WomenEthn Dis201727218920028439190
   PubMed Web of Science ®Google Scholar
• SobieszczykMEWernerLMlisanaKMetabolic syndrome after HIV acquisition in South African womenJ Acquir Immune Defic Syndr201673443844527391387
   PubMed Web of Science ®Google Scholar
• MuyanjaDMuzooraCMuyingoAMuyindikeWSiednerMJHigh prevalence of metabolic syndrome and cardiovascular disease risk among people with HIV on stable ART in Southwestern UgandaAIDS Patient Care STDs201630141026683587
   PubMed Web of Science ®Google Scholar
• GuiraOTiénoHDiendéréAEFeatures of metabolic syndrome and its associated factors during highly active antiretroviral therapy in Ouagadougou (Burkina Faso)J Int Assoc Provid AIDS Care201615215916326307211
   PubMedGoogle Scholar
• EholiéSPLacombeKKrainAMetabolic disorders and cardiovascular risk in treatment-naive HIV-infected patients of Sub-Saharan origin starting antiretrovirals: impact of westernized lifestyleAIDS Res Hum Retroviruses201531438439225707418
   PubMed Web of Science ®Google Scholar
• TesfayeDYKindeSMedhinGBurden of metabolic syndrome among HIV-infected patients in Southern EthiopiaDiabetes Metab Syndr20148210210724907175
   PubMedGoogle Scholar
• AyodeleOEAkinboroAOAkinyemiSOPrevalence and clinical correlates of metabolic syndrome in Nigerians living with human immunodeficiency virus/acquired immunodeficiency syndromeMetab Syndr Relat Disord201210537337922799758
   PubMed Web of Science ®Google Scholar
• ZannouDMDenoeudLLacombeKIncidence of lipodystrophy and metabolic disorders in patients starting non-nucleoside reverse transcriptase inhibitors in BeninAntivir Ther200914337138019474471
   PubMed Web of Science ®Google Scholar
• DimalaCAAtashiliJMbuagbawJCWilfredAMonekossoGLPrevalence of hypertension in HIV/AIDS patients on highly active anti-retroviral therapy (HAART) compared with HAART-naive patients at the Limbe regional hospital, CameroonPLoS One2016112e014810026862763
   PubMed Web of Science ®Google Scholar
• Longo-MbenzaBRelationship between younger age, autoimmunity, cardiometabolic risk, oxidative stress, HAART, and ischemic stroke in Africans with HIV/AIDSISRN Cardiol2011201189790822347662
   PubMedGoogle Scholar
• TchoungaBKHøngeBLEholieSPIeDEA West Africa CollaborationEffect of sex and age on outcomes among HIV-2 infected patients starting antiretroviral therapy in West AfricaAIDS201630172707271427536979
   PubMed Web of Science ®Google Scholar
• FelekeYFekadeDMezegebuYPrevalence of highly active antiretroviral therapy associated metabolic abnormalities and lipodystrophy in HIV infected patientsEthiop Med J201250322123023409405
   PubMedGoogle Scholar
• DioufACournilAGroupe d’étude de la Cohorte ANRS 1215Prevalence of metabolic complications after 10 years of antiretroviral treatment in SenegalBull Soc Pathol Exot20141074234237 Article in French24683016
   PubMedGoogle Scholar
• FrantzJMMurenziAThe physical activity levels among people living with human immunodeficiency virus/acquired immunodeficiency syndrome receiving high active antiretroviral therapy in RwandaSAHARA J2013103–411311824521093
   PubMed Web of Science ®Google Scholar
• NgatchouWLemogoumDNdoboPIncreased burden and severity of metabolic syndrome and arterial stiffness in treatment-naive HIV+ patients from CameroonVasc Health Risk Manag2013950951624043942
   PubMedGoogle Scholar
• BerhaneTYamiAAlemsegedFPrevalence of lipodystrophy and metabolic syndrome among HIV positive individuals on highly active anti-retroviral treatment in Jimma, South West EthiopiaPan Afr Med J2012134323330034
   PubMedGoogle Scholar
• ArmstrongCLiuEOkumaJDyslipidemia in an HIV-positive antiretroviral treatment-naive population in Dar es Salaam, TanzaniaJ Acquir Immune Defic Syndr201157214114521436713
   PubMed Web of Science ®Google Scholar
• BekoloCENguenaMBEwaneLBekoulePSKolloBThe lipid profile of HIV-infected patients receiving antiretroviral therapy in a rural Cameroonian populationBMC Public Health20141423624606888
   PubMed Web of Science ®Google Scholar
• NgalaRAFiankoKDyslipidaemia and dysglycaemia in HIV-infected patients on highly active anti-retroviral therapy in Kumasi MetropolisAfr Health Sci20131341107111624940339
   PubMedGoogle Scholar
• DaveJALevittNSRossILLacerdaMMaartensGBlomDAnti-retroviral therapy increases the prevalence of dyslipidemia in South African HIV-infected patientsPLoS One2016113e015191126986065
   PubMed Web of Science ®Google Scholar
• JuliusHBasuDRicciEThe burden of metabolic diseases amongst HIV positive patients on HAART attending The Johannesburg HospitalCurr HIV Res20119424725221631427
   PubMed Web of Science ®Google Scholar
• LesiOASoyebiKSEbohCNFatty liver and hyperlipidemia in a cohort of HIV-positive Africans on highly active antiretroviral therapyJ Natl Med Assoc2009101215115519378632
   PubMed Web of Science ®Google Scholar
• SalamiAKAkandeAAOlokobaABSerum lipids and glucose abnormalities in HIV/AIDS patients on antiretroviral therapiesWest Afr J Med2009281101519662738
   PubMedGoogle Scholar
• MuronyaWSangaETalamaGKumwendaJJvan OosterhoutJJCardiovascular risk factors in adult Malawians on long-term antiretroviral therapyTrans R Soc Trop Med Hyg20111051164464921924753
   PubMed Web of Science ®Google Scholar
• AhmedMHWoodwardCMitalDMetabolic clinic for individuals with HIV/AIDS: a commitment and vision to the future of HIV servicesCardiovasc Endocrinol201763109112
   Google Scholar